Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > A Lottery ticket with extras.

<< Previous

Bullboard Posts

Next >>

Post by Lookingforclueson Jun 27, 2021 9:05pm

170 Views

Post# 33458238

A Lottery ticket with extras.

Seriously, he/she gets paid for this....

I suppose that SH lets Companies pay to be on here, so perhaps it is as Mugs etc., etc., ..says.
It's a 'Paid Position......7 years and the Company is now worth half and the same with Antibe....Gruesome!

<< Previous

Bullboard Posts

Next >>

Gold, growth and sustainability in focus for Mandalay Resources